Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:50:12 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



Q:TNXP - TONIX PHARMACEUTICALS HLDG CORP - http://www.tonixpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TNXP - Q0.10.1759·0.209.80.1816    2.1253  0.120206:20:56May 1515 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
06:20:56Q0.19230.01071
04:32:02Q0.190.00841,462
04:28:36Q0.190.00842,573
04:28:03Q0.18990.0083500
04:28:03Q0.18990.00832,500
04:26:46Q0.190.00849,727
04:26:46Q0.18990.0083273
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-15 08:00U:TNXPNews ReleaseTonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
2024-05-13 16:30U:TNXPNews ReleaseTonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
2024-04-24 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
2024-04-01 16:15U:TNXPNews ReleaseTonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
2024-03-28 09:33U:TNXPNews ReleaseTonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
2024-03-25 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
2024-03-21 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
2024-03-20 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya(TM) for the Management of Fibromyalgia
2024-03-19 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024
2024-03-12 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
2024-03-11 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Reports Improvement in "Brain Fog," in Fibromyalgia Patients Treated with Tonmya(TM) in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia
2024-03-07 09:37U:TNXPNews ReleaseNew to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT
2024-03-07 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy
2024-03-06 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Selects EVERSANA(TM) to Support Launch Strategy and Commercialization Planning of Tonmya(TM) for the Management of Fibromyalgia
2024-03-05 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans
2024-02-29 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia
2024-02-28 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers
2024-02-28 06:57U:TNXPNews ReleaseTonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial
2024-02-28 06:55U:TNXPNews ReleaseTonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation
2024-02-27 08:00U:TNXPNews ReleaseTonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya(TM) to Support Development and Partnering in Japan and China